(PharmaNewsWire.Com, January 11, 2017 ) Neurostimulation devices are gaining acceptance as an alternative therapy for certain chronic pain conditions. These devices have also been used in the management of neurological disorders like Parkinson's disease and epilepsy. The currently available neurostimulators mainly focus on SCS, deep brain stimulation (DBS), vagus nerve stimulation (VNS), and sacral nerve stimulation (SNS).
Publisher's analysts forecast the global spinal cord stimulation (SCS) devices market to grow at a CAGR of 4.84% during the period 2016-2020. For more information about this report: http://www.reportsweb.com/global-spinal-cord-stimulation-devices-market-2016-2020 Covered in this report The report covers the present scenario and the growth prospects of the global spinal cord stimulation (SCS) devices market for 2016-2020. To calculate the market size, we consider the revenue generated from the sale of SCS devices.
The market is divided into the following segments based on geography: - Americas - APAC - EMEA
Publisher's report, Global Spinal Cord Stimulation (SCS) Devices Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors - Boston Scientific - Medtronic - Nevro - St. Jude Medical
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: